Communiqués Azenta, Inc.

Actions

AZTA

US1143401024

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq Autres places de cotation 22:00:01 23/06/2026			Varia. 5j.	Varia. 1 janv.
22,20 ^USD	-0,31%		-4,02%	-33,25%

07/05	AZENTA, INC. : Needham & Co. toujours à l'achat	ZM
06/05	Transcript : Azenta, Inc., Q2 2026 Earnings Call, May 06, 2026

Communiqués

21/05	Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report	PR
06/05	Azenta : Presentation (Q2 26 Earnings Deck FINAL 05 05 26)	PU
06/05	Azenta : Press Release (Q2 26 Earnings Release 05 05 26)	PU
06/05	Azenta : Supplemental Information (Q2 26 Earnings Supplemental Letter 05 05 26)	PU
05/05	Azenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and Extends Long-Range Plan to 2029	PR
29/04	Azenta Announces Fiscal 2026 Second Quarter Conference Call and Webcast	PR
07/04	Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution	PR
04/03	Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities	PR
24/02	Azenta to Participate in Raymond James 47th Annual Institutional Investor Conference	PR
09/02	Azenta Life Sciences and Frontier Space Announce Strategic Partnership to Advance Space-Based Life Sciences Research Infrastructure	PR
04/02	Azenta Reports First Quarter Results for Fiscal 2026, Ended December 31, 2025	PR
21/01	Azenta Announces Fiscal 2026 First Quarter Conference Call and Webcast	PR
30/12	Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.A R.L.	AQ
29/12	Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L.	PR
10/12	Azenta : 2025 Investor Day Presentation	PU
10/12	Azenta Authorizes $250 Million Share Repurchase Program	PR
21/11	Azenta Reports Fourth Quarter and Full Year Fiscal 2025 Results, Ended September 30, 2025	PR
12/11	Azenta Announces Fiscal 2025 Fourth Quarter and Full Year Conference Call and Webcast	PR
04/11	Azenta Life Sciences Partners with PRECEDE Foundation to Advance Early Detection of Pancreatic Cancer	PR
15/10/25	Azenta to Host Investor Day at its Biorepository Facility in Indianapolis, Indiana	PR
05/08/25	Azenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 Guidance	PR
31/07/25	Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology	PR
31/07/25	Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care	PR
30/07/25	Azenta to Participate in 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference	PR
23/07/25	Azenta Announces Fiscal 2025 Third Quarter Earnings Conference Call and Webcast	PR